Atara Biotherapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €151.24M +117.9% €55.95M -2,132.3% 37.0% +0.41 pp N/A N/A
    (estimated) €69.41M +110.8% -€2.75M -92.3% -4.0% +1.0 pp N/A N/A
    (estimated) €32.92M -35.8% -€35.82M +3,673.6% -108.8% -1.1 pp N/A N/A
    (estimated) €51.30M -51.2% -€949.34K -104.2% -1.9% -0.23 pp N/A N/A
    (estimated) €105.07M -5.6% €22.46M -130.5% 21.4% +0.88 pp N/A N/A
    €111.28M +1,404.0% -€73.71M -69.1% -66.2% +32 pp -€59.09M -64.3% -53.1% +22 pp
    €7.40M -86.5% -€238.31M -87.9% -3,220.9% +3.7 pp -€165.49M -28.0% -2,236.7% -18 pp
    €54.87M +212.6% -€1.97B -32.9% -3,591.2% +130 pp -€229.77M +26.8% -418.8% +6.1 pp
    €17.55M +∞% -€2.94B +10.9% -16,722.8% -170 pp -€181.19M +19.1% -1,032.2% -10 pp
    €0.00 +NaN% -€2.65B +5.4% N/A -€152.11M -23.3% N/A
    €0.00 +NaN% -€2.51B +26.1% N/A -€198.41M +59.8% N/A
    €0.00 +NaN% -€1.99B +93.1% N/A -€124.15M +113.8% N/A
    €0.00 +NaN% -€1.03B +51.2% N/A -€58.06M +18.0% N/A
    €0.00 +NaN% -€682.22M +38.1% N/A -€49.20M +54.6% N/A
    €0.00 +NaN% -€493.84M +104.3% N/A -€31.82M +122.3% N/A
    €0.00 +NaN% -€241.70M +219.2% N/A -€14.31M +178.1% N/A
    €0.00 +NaN% -€75.71M -28.8% N/A -€5.15M +143.6% N/A
    €0.00 -€106.41M N/A -€2.11M N/A

    Notifications